Report cover image

Psoriatic Arthritis Treatment Market Report and Forecast 2025-2034

Publisher Expert Market Research
Published Jul 28, 2025
Length 350 Pages
SKU # EMAR20319814

Description

The psoriatic arthritis treatment market value was USD 13.38 Billion in 2024, driven by the prevalence of psoriatic arthritis across the globe. The market size is anticipated to grow at a CAGR of 9.80% during the forecast period of 2025-2034 to achieve a value of USD 34.08 Billion by 2034.

It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.

Market Segmentation

Psoriatic arthritis is a chronic psoriasis-related degenerative disorder. Swollen fingers, toes, and tender joints, stiffness, lowered back pain, and pitted nails are prevalent symptoms of psoriatic arthritis. Psoriatic arthritis treatment market can be divided on the basis of segments like drug class, product type and administration route.

Market Breakup by Drug Class
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Disease-Modifying Antirheumatic Drugs (DMARDs)
  • Immunosuppressants
  • Biological Agents
  • Corticosteroids
  • Others
Market Breakup by Route of Administration
  • Oral
  • Parenteral
  • Topical
Market Breakup by Drug Type
  • Prescription
  • Over The Counter
Market Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Analysis

The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is driving the global psoriatic arthritis treatment industry. The other factors aiding in the growth of the industry are investments by major companies in clinical R&D, new product launches, increasing disease prevalence and proactive government initiatives. The factors such as high cost of treatment, stringent regulatory approval and adverse effect of drugs may hinder the growth of the market in coming future.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global psoriatic arthritis treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
  • AbbVie Inc.
  • Janssen Global Services, LLC (Johnson & Johnson)
  • Novartis AG
  • Amgen Inc.
  • Biogen Inc.
  • Pfizer Inc.
  • Eli Lilly and Company
  • UCB S.A.
  • Bristol-Myers Squibb Company
  • Merck & Co. Inc.
  • Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.

Key Highlights of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
  • Drug Class
  • Route of Administration
  • Drug Type
  • Distribution Channel
  • Region
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Disease-Modifying Antirheumatic Drugs (DMARDs)
  • Immunosuppressants
  • Biological Agents
  • Corticosteroids
  • Others
  • Oral
  • Parenteral
  • Topical
  • Prescription
  • Over The Counter
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
  • Market Structure
  • Company Profiles
  
  • Financial Analysis

    •   
  • Product Portfolio

    •   
  • Demographic Reach and Achievements

    •   
  • Mergers and Acquisitions

    •   
  • Certifications
    • AbbVie Inc.
    • Janssen Global Services, LLC (Johnson & Johnson)
    • Novartis AG
    • Amgen Inc.
    • Biogen Inc.
    • Pfizer Inc.
    • Eli Lilly and Company
    • UCB S.A.
    • Bristol-Myers Squibb Company
    • Merck & Co. Inc.
    • Others
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Psoriatic Arthritis Overview
    3.1 Guidelines and Stages
    3.2 Pathophysiology
    3.3 Screening and Diagnosis
    3.4 Treatment Pathway
    4 Patient Profile
    4.1 Patient Profile Overview
    4.2 Patient Psychology and Emotional Impact Factors
    4.3 Risk Assessment and Treatment Success Rate
    5 Psoriatic Arthritis Epidemiology Analysis
    5.1 Epidemiology Overview (2018-2034)
    5.2 North America Psoriatic Arthritis Epidemiology (2018-2034)
    5.3 Europe Psoriatic Arthritis Epidemiology (2018-2034)
    5.4 Asia-Pacific Psoriatic Arthritis Epidemiology (2018-2034)
    5.5 Latin America Psoriatic Arthritis Epidemiology (2018-2034)
    5.6 Middle East & Africa Psoriatic Arthritis Epidemiology (2018-2034)
    6 Global Psoriatic Arthritis Treatment Market Overview
    6.1 Global Psoriatic Arthritis Treatment Market Historical Value (2018-2024)
    6.2 Global Psoriatic Arthritis Treatment Market Forecast Value (2025-2034)
    7 Global Psoriatic Arthritis Treatment Market Landscape
    7.1 Psoriatic Arthritis Therapeutics: Developers Landscape
    7.1.1 Analysis by Year of Establishment
    7.1.2 Analysis by Company Size
    7.1.3 Analysis by Region
    7.2 Psoriatic Arthritis Therapeutics: Product Landscape
    7.2.1 Analysis by Drug Class
    7.2.2 Analysis by Drug Type
    7.2.3 Analysis by Route of Administration
    8 Psoriatic Arthritis Therapeutics Challenges and Unmet Needs
    8.1 Treatment Pathway Challenges
    8.2 Compliance and Drop-Out Analysis
    8.3 Awareness and Prevention Gaps
    9 Cost of Treatment
    10 Global Psoriatic Arthritis Treatment Market Dynamics
    10.1 Market Drivers and Constraints
    10.2 SWOT Analysis
    10.3 Porter’s Five Forces Model
    10.4 Key Demand Indicators
    10.5 Key Price Indicators
    10.6 Industry Events, Initiatives, and Trends
    10.7 Value Chain Analysis
    11 Global Psoriatic Arthritis Treatment Market Segmentation
    11.1 Global Psoriatic Arthritis Treatment Market by Drug Class
    11.1.1 Market Overview
    11.1.2 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    11.1.3 Disease-Modifying Antirheumatic Drugs (DMARDs)
    11.1.4 Immunosuppressants
    11.1.5 Biological Agents
    11.1.6 Corticosteroids
    11.1.7 Others
    11.2 Global Psoriatic Arthritis Treatment Market by Route of Administration
    11.2.1 Market Overview
    11.2.2 Oral
    11.2.3 Parenteral
    11.2.4 Topical
    11.3 Global Psoriatic Arthritis Treatment Market by Drug Type
    11.3.1 Market Overview
    11.3.2 Prescription
    11.3.2.1 Branded
    11.3.2.2 Generics
    11.3.3 Over The Counter
    11.4 Global Psoriatic Arthritis Treatment Market by Distribution Channel
    11.4.1 Market Overview
    11.4.2 Hospital Pharmacies
    11.4.3 Retail Pharmacies
    11.4.4 Online Pharmacies
    11.5 Global Psoriatic Arthritis Treatment Market by Region
    11.5.1 Market Overview
    11.5.2 North America
    11.5.3 Europe
    11.5.4 Asia Pacific
    11.5.5 Latin America
    11.5.6 Middle East and Africa
    12 North America Psoriatic Arthritis Therapeutics Market
    12.1 Market Share by Country
    12.2 United States of America
    12.3 Canada
    13 Europe Psoriatic Arthritis Therapeutics Market
    13.1 Market Share by Country
    13.2 United Kingdom
    13.3 Germany
    13.4 France
    13.5 Italy
    13.6 Others
    14 Asia Pacific Psoriatic Arthritis Therapeutics Market
    14.1 Market Share by Country
    14.2 China
    14.3 Japan
    14.4 India
    14.5 ASEAN
    14.6 Australia
    14.7 Others
    15 Latin America Psoriatic Arthritis Therapeutics Market
    15.1 Market Share by Country
    15.2 Brazil
    15.3 Argentina
    15.4 Mexico
    15.5 Others
    16 Middle East and Africa Psoriatic Arthritis Therapeutics Market
    16.1 Market Share by Country
    16.2 Saudi Arabia
    16.3 United Arab Emirates
    16.4 Nigeria
    16.5 South Africa
    16.6 Others
    17 Regulatory Framework
    17.1 Regulatory Overview
    17.1.1 US FDA
    17.1.2 EU EMA
    17.1.3 INDIA CDSCO
    17.1.4 JAPAN PMDA
    17.1.5 Others
    18 Patent Analysis
    18.1 Analysis by Type of Patent
    18.2 Analysis by Publication year
    18.3 Analysis by Issuing Authority
    18.4 Analysis by Patent Age
    18.5 Analysis by CPC Analysis
    18.6 Analysis by Patent Valuation
    18.7 Analysis by Key Players
    19 Grants Analysis
    19.1 Analysis by year
    19.2 Analysis by Amount Awarded
    19.3 Analysis by Issuing Authority
    19.4 Analysis by Grant Application
    19.5 Analysis by Funding Institute
    19.6 Analysis by NIH Departments
    19.7 Analysis by Recipient Organization
    20 Clinical Trials Analysis
    20.1 Analysis by Trial Registration Year
    20.2 Analysis by Trial Status
    20.3 Analysis by Trial Phase
    20.4 Analysis by Therapeutic Area
    20.5 Analysis by Geography
    21 Funding and Investment Analysis
    21.1 Analysis by Funding Instances
    21.2 Analysis by Type of Funding
    21.3 Analysis by Funding Amount
    21.4 Analysis by Leading Players
    21.5 Analysis by Leading Investors
    21.6 Analysis by Geography
    22 Partnership and Collaborations Analysis
    22.1 Analysis by Partnership Instances
    22.2 Analysis by Type of Partnership
    22.3 Analysis by Leading Players
    22.4 Analysis by Geography
    23 Supplier Landscape
    23.1 AbbVie Inc.
    23.1.1 Financial Analysis
    23.1.2 Product Portfolio
    23.1.3 Demographic Reach and Achievements
    23.1.4 Mergers and Acquisitions
    23.1.5 Certifications
    23.2 Janssen Global Services, LLC (Johnson & Johnson)
    23.2.1 Financial Analysis
    23.2.2 Product Portfolio
    23.2.3 Demographic Reach and Achievements
    23.2.4 Mergers and Acquisitions
    23.2.5 Certifications
    23.3 Novartis AG
    23.3.1 Financial Analysis
    23.3.2 Product Portfolio
    23.3.3 Demographic Reach and Achievements
    23.3.4 Mergers and Acquisitions
    23.3.5 Certifications
    23.4 Amgen Inc.
    23.4.1 Financial Analysis
    23.4.2 Product Portfolio
    23.4.3 Demographic Reach and Achievements
    23.4.4 Mergers and Acquisitions
    23.4.5 Certifications
    23.5 Biogen Inc.
    23.5.1 Financial Analysis
    23.5.2 Product Portfolio
    23.5.3 Demographic Reach and Achievements
    23.5.4 Mergers and Acquisitions
    23.5.5 Certifications
    23.6 Pfizer Inc.
    23.6.1 Financial Analysis
    23.6.2 Product Portfolio
    23.6.3 Demographic Reach and Achievements
    23.6.4 Mergers and Acquisitions
    23.6.5 Certifications
    23.7 Eli Lilly and Company
    23.7.1 Financial Analysis
    23.7.2 Product Portfolio
    23.7.3 Demographic Reach and Achievements
    23.7.4 Mergers and Acquisitions
    23.7.5 Certifications
    23.8 UCB S.A.
    23.8.1 Financial Analysis
    23.8.2 Product Portfolio
    23.8.3 Demographic Reach and Achievements
    23.8.4 Mergers and Acquisitions
    23.8.5 Certifications
    23.9 Bristol-Myers Squibb Company
    23.9.1 Financial Analysis
    23.9.2 Product Portfolio
    23.9.3 Demographic Reach and Achievements
    23.9.4 Mergers and Acquisitions
    23.9.5 Certifications
    23.10 Merck & Co. Inc.
    23.10.1 Financial Analysis
    23.10.2 Product Portfolio
    23.10.3 Demographic Reach and Achievements
    23.10.4 Mergers and Acquisitions
    23.10.5 Certifications
    23.11 Others
    24 Psoriatic Arthritis Therapeutics - Distribution Model (Additional Insight)
    24.1 Overview
    24.2 Potential Distributors
    24.3 Key Parameters for Distribution Partner Assessment
    25 Key Opinion Leaders (KOL) Insights (Additional Insight)
    26 Company Competitiveness Analysis (Additional Insight)
    26.1 Very Small Companies
    26.2 Small Companies
    26.3 Mid-Sized Companies
    26.4 Large Companies
    26.5 Very Large Companies
    27 Payment Methods (Additional Insight)
    27.1 Government Funded
    27.2 Private Insurance
    27.3 Out-of-Pocket

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us